Eskape Pathogens Detection Mechanisms And Treatment Strategies Siddhardha Busi by Siddhardha Busi, Ram Prasad, (editors) 9789819987986, 9819987989 instant download after payment.

ESKAPE pathogens—the ‘escapers’ from the biocidal action of antibiotics—comprise Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. Infectious diseases due to this group of bacteria continue to be one of the most alarming health issues that cost millions of lives globally. Also, this group of bacteria is the most encountered nosocomial pathogens and is highly resistant to commonly used antibiotics. Noticeably, now reports on strains developing resistance to last-resort antibiotics are also frequent. Not surprisingly, this alarming situation of antimicrobial resistance (AMR) has been declared a threat to human and animal health by the WHO and CDC. According to the current rate of emergence and spread of antibiotic resistance, it is expected that the annual loss of life will reach around ten million deaths with an estimated economic loss of 100 trillion dollars by the year 2050. In the US and Europe, AMR infections account for three million cases costing over 6.2 billion USD annually. Estimated figures are not available for the LMIC countries, although, undoubtedly, they also highly contribute to harbouring MDR pathogens.